Publications

Selected publications

Murphy BP, Pang TYC, Hannan AJ, Proffitt TM, McConchie M, Kerr M, O'Donnell C, McGorry PD, Berger GE. Vascular endothelial growth factor and brain-derived neurotrophic in quetiapine treated first-episode psychosis. Schizophr Res Treatment (2014) doi: 10.1155/2014/719395.

Cotton SM, McCann T, Gleeson JF, Crisp K, Murphy BP & Lubman, DI. Coping strategies in carers of young people with a first episode of psychosis. Schizophrenia Research (2013) 146: 118-124.

Lee VW, Murphy BP. Broadening the early intervention paradigm: a one stop shop for youth. Early Intervention in Psychiatry (2013) 7(4): 437-41.

Malone A, Carroll A, Murphy BP. Facial affect recognition deficits: A potential contributor to aggression in first-episode psychosis. Aggression and Violent Behaviour (2012) 17: 27-35.

McCann TV, Lubman DI, Cotton SM, Murphy BP, Crisp K, Catania L, Marck C & Gleeson JFM. A Randomized Controlled Trial of Bibliotherapy for Carers of Young People with First-Episode Psychosis. Schizophrenia Bulletin sbs121 (2012) 39(6): 1307-17.

Edwards J, Cocks J, Burnett P, Maud D, Wong L, Yuen HP, Harrigan SM, Hermann-Doig T, Murphy BP, Wade D, McGorry PD. Randomized Controlled Trial of Clozapine and CBT for First-Episode Psychosis with Enduring Positive Symptoms: A Pilot Study. Schizophrenia Research and Treatment (2011) Article ID 394896, 8 pages, doi:10.1155/2011/394896.

Murphy BP & Brewer WJ. Strengths and Limitations of Early Intervention in Psychosis: Service elements. Advances in Psychiatric Treatment (2011) 17: 401-7.

Murphy BP & Brewer WJ. Strengths and Limitations of Early Intervention in Psychosis: Clinical aspects. Advances in Psychiatric Treatment (2011) 17: 408-16.

Conus., P., Berk, M., Cotton, S., Kader, L., Macneil, C., Hasty, M., Hallam, K., Lucas, N., Ward, J., Eide, P., Lambert, M., Murphy, B., McGorry, P.D. (2010) Randomized controlled trial of olanzapine or chlorpromazine as addition to lithium in the treatment of a first manic episode with psychotic features: an 8 weeks, flexible dose, single blind trial. Archives of General Psychiatry (under review).

Murphy, BP. Beyond the first episode: candidate factors for a risk prediction model of schizophrenia. Int Rev Psychiatry. 2010;22(2):202-23.

Berk M , Hallam K, Malhi GS, Henry L, Hasty M, Macneil M, Yucel M, Pantelis C, Murphy BP, Vieta E, Dodd S, McGorry PD. Evidence and implications for early intervention in bipolar disorder. Journal of Mental Health (2010) 19, 2: 1-13.

Lenné MG, Dietze PM, Triggs TJ, Walmsley S, Murphy BP, Redman JR. The effects of cannabis and alcohol on simulated arterial driving: Influences of driving experience and task demand. Accident; Analysis and Prevention (2010) 42 (3): 859-66.

Foley, D.L., Morley KI, Carroll K, Moran J, McGorry PD Murphy, B.P., Successful implementation of cardiometabolic monitoring of patients treated with antipsychotics. MJA (2009) 191 (9): 518-9.

Berk M , Hallam K, Malhi GS, Henry L, Hasty M, Macneil M, Yucel M, Pantelis C, Murphy B, Vieta E, Dodd S, McGorry PD Evidence and implications for early intervention in bipolar disorder. Journal of Mental Health (accepted October 2009).

Brewer, W.J., Witt, K., Gee, D., Duff, C., Crlenjak, C., Lambert, T.J., McGorry, P.D. & Murphy, B.P. (2009) Efficacy of Intensive Case Management in First Episode Psychosis: Maximising Recovery and Outcome in a High Risk Group. Acta Psychiatrica Scandinavica (under review).

Brewer, W.J., Witt, K., Lambert, T.J., McGorry, P.D. & Murphy, B.P. Intensive Case Management in First Episode Psychosis: Maximising Prognosis in a High Risk Group (2009) Psychiatric Services (under review).

Murphy, B.P., Simms, C., Dowling, R-M., Graham, A., Doherty, A., Meadows, G. On giant's shoulders: development of the Recovery and Prevention of Psychosis Service (RAPPS) in Melbourne. Early Intervention in Psychiatry (2009) 3: 151-156.

Allott, A., Canny, B. J., Broadbear, J. H., Stepto, N. K., Murphy, B. P., Redman, J. Neuroendocrine and subjective responses to pharmacological challenge with citalopram: A controlled study in male and female ecstasy/MDMA users. Journal of Psychopharmacology (2008) 23 (7): 759-774.

Murphy, B.P. Letter to the editor: Inconclusive Evidence for the Efficacy of Olanzapine in the Treatment of Negative Symptoms in Schizophrenia. Journal of Clinical Psychiatry (2008) 69, 164.

Murphy, B.P., Stuart, A., McGorry, P.D. Duration of untreated negative symptoms (DUNS) and duration of active negative symptoms (DANS): proof of concepts using a first-episode schizophrenic sample. Early Intervention in Psychiatry (2008) 2: 27-33.

Murphy, B.P., Chung, Y-C., Park, T.W., McGorry, P.D. Pharmacological treatment of primary negative symptoms in schizophrenia: a systematic review. Schizophrenia Research (December 2006) 88: 5-25.

Murphy, B.P., Stuart, A., Wade, D., Cotton, S., McGorry, P.D. Efficacy of amisulpride in treating primary negative symptoms in first-episode psychosis: a pilot study. Human Psychopharmacology (December 2006) 21: 511-517.

Conference papers/published abstracts

Allott, K., Redman, J., Murphy, B.P. Sex differences associated with the psychological, physiological and neurological effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA): a review of the literature. Poster presented at the 3rd International Congress on Women's Mental Health, Melbourne, Australia (2008).

Brewer WJ, Gleeson J, Gee D, Murphy BP, Lambert T, McGorry PD. Prevalence of antisocial personality traits and disorder in first episode psychosis cohorts. 6th International Conference on Early Psychosis, Melbourne. Early Intervention in Psychiatry (2008) Vol 2 Suppl 1 A43.

Brewer WJ, Lambert T, Gee D, Duff C, Crlenjak C, Bott J, Murphy BP, McGorry PD. Intensive case management of high suicide risk early psychosis clients: neuropsychological perspective of adolescent trajectories into psychopathology. 6th International Conference on Early Psychosis, Melbourne. Early Intervention in Psychiatry (2008) Vol 2 Suppl 1. A26.

Crlenjak C, Gee D, Duff C, Bott J, Murphy BP, McGorry PD, Lambert T, Brewer WJ. Engaging high suicide risk early psychosis clients via intensive case management. 6th International Conference on Early Psychosis, Melbourne. Early Intervention in Psychiatry (2008) Vol 2 Suppl 1 A82.

Duff C, Gee D, Crlenjak C, Bott J, Murphy BP, McGorry PD, Lambert T, Brewer WJ Management of high suicide risk early psychosis clients via intensive case management: nursing perspectives. 6th International Conference on Early Psychosis, Melbourne. Early Intervention in Psychiatry (2008) Vol 2 Suppl 1 A83.

Lambert T, Brewer WJ, Gee D, Duff C, Crlenjak C, Bott J, Murphy BP, McGorry PD. Intensive case management of high suicide risk early psychosis clients: managing multidimensional outcomes. 6th International Conference on Early Psychosis, Melbourne. Early Intervention in Psychiatry (2008) Vol 2 Suppl 1 A29.

Murphy BP. Research projects in Youth Early Psychosis undertaken as part of the delivery of service by the Recovery and Prevention from Psychosis Service (RAPPS) 6th International Conference on Early Psychosis, Melbourne. Early Intervention in Psychiatry (2008) Vol 2 Suppl 1 A89.

Murphy BP. Introduction to symposium and overview of negative symptoms. 6th International Conference on Early Psychosis, Melbourne. Early Intervention in Psychiatry (2008) Vol 2 Suppl 1 A64.

Murphy BP, Chung Y-C. Pharmacological treatment of primary negative symptoms in schizophrenia: a systematic review. 6th International Conference on Early Psychosis, Melbourne. Early Intervention in Psychiatry (2008) Vol 2 Suppl 1 A64.

Murphy BP, Stuart AH, McGorry PD. The Negative Symptom Onset Scale - a new tool to assist the research and clinical management of negative symptoms: reliability and validity. 6th International Conference on Early Psychosis, Melbourne. Early Intervention in Psychiatry (2008) Vol 2 Suppl 1 A65.

Murphy BP, Stuart AH, McGorry PD (2007) Duration of untreated negative symptoms (DUNS) and duration of active negative symptoms (DANS): Proof of concepts. WPA International Congress. Melbourne, Australian and New Zealand Journal of Psychiatry 2007; 41 Supplement 2: A274.

Murphy BP, Stuart AH, Wade D, Cotton S, McGorry PD (2007) Efficacy of amisulpride in treating primary negative symptoms in first-episode psychosis: a pilot study. WPA International Congress. Melbourne, Australian and New Zealand Journal of Psychiatry 2007; 41 Supplement 2: A273.

Brewer, W.J., Murphy, B.P., Lambert, T., Harris, M.G., Staude, G., Briggs, S., McGorry, P.D. (2006) Intensive case management (ICM) for high suicide risk: Evaluating a unique model of care for poorly engaged clients with first episode psychosis. XIIIth Biennial Winter Workshop on Schizophrenia Research, Davos, Switzerland Feb 4-10th, Schizophrenia Research, 81 (Supp): 229.